636-97-5Relevant articles and documents
Visual and near IR (NIR) fluorescence detection of Cr3+ in aqueous media via spirobenzopyran ring opening with application in logic gate and bio-imaging
Goswami, Shyamaprosad,Das, Avijit Kumar,Maity, Anup Kumar,Manna, Abhishek,Aich, Krishnendu,Maity, Sibaprasad,Saha, Partha,Mandal, Tarun Kanti
, p. 231 - 239 (2014)
A new spirobenzopyran derivative (SPNH) was designed and synthesized which was applied in simultaneous colorimetric and NIR fluorescence detections for Cr3+. This spirobenzopyran receptor is normally colorless in aqueous organic media but the formation of merocyanine occurs by Cr3+ showing a yellow color. Here the formation of yellow color in UV-vis spectra and strong NIR fluorescence emission at 675 nm makes SPNH a good sensor for Cr 3+ ion. It is also found to be useful in cell imaging and in construction of logic gate. It shows INHIBIT gate in fluorescence and OR gate in absorption. To the best of our knowledge, this is the first report of NIR fluorescence emission of a spirobenzopyran derivative by Cr3+ and its application to cell-biology and also in the logic gate.
A simple naphthalene-based colorimetric sensor selective for acetate
Goswami, Shyamaprosad,Das, Avijit Kumar,Sen, Debabrata,Aich, Krishnendu,Fun, Hoong-Kun,Quah, Ching Kheng
, p. 4819 - 4823 (2012)
A new naphthalene based receptor (L) has been designed and synthesized which shows a remarkable color change from colorless to pink on selective binding with acetate. The anion recognition property of the receptor via hydrogen bonding interactions is monitored by UV-vis, fluorescence, and 1H NMR titrations. It is observed that in each case, the receptor shows a specific selectivity toward the acetate ion over other interfering anions. Thus, a significant bathochromic shift in UV-vis spectrum with a sharp pink color in 'naked-eye' makes the receptor suitable for the detection of the acetate ion.
Design and synthesis of novel 1,3,4-oxadiazole based azaspirocycles catalyzed by NaI under mild condition and evaluated their antidiabetic and antibacterial activities
Radia, Ashish J.,Lalpara, Jaydeep N.,Modasiya, Ishita J.,Dubal, Gaurang G.
, p. 612 - 621 (2020/12/14)
A modest, efficient, and mild synthetic procedure has been developed for the synthesis of novel series of 1,3,4-oxadiazole containing azaspirocycles derivatives. The reaction of 1,3,4-oxadiazole derivative with diverse azaspiro compounds under room temperature condition with helps of sodium iodide catalyst and polar aprotic solvent. Numerous compensations of this strategy embrace less time required, yield increment, consumption of all reactants, and mild condition. All synthesized compounds evaluated for in vitro antidiabetic and antibacterial screening. Among them some compounds show significant biological response.
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4-triazole scaffolds
Pathak, Prateek,Novak, Jurica,Shukla, Parjanya K.,Grishina, Maria,Potemkin, Vladimir,Verma, Amita
, (2021/03/08)
Bacterial infections are a serious threat to human health due to the development of resistance against the presently used antibiotics. The problem of growing and widespread antibiotic resistance is only getting worse with the shortage of new classes of antibiotics, creating a substantial unmet medical need in the treatment of serious bacterial infections. Therefore, in the present work, we report 18 novel hybrid thiazolidine–1,2,4-triazole derivatives as DNA gyrase inhibitors. The derivatives were synthesized by multistep organic synthesis and characterized by spectroscopic methods (1H and 13C nuclear magnetic resonance and mass spectroscopy). The derivatives were tested for DNA gyrase inhibition, and the result emphasized that the synthesized derivatives have a tendency to inhibit the function of DNA gyrase. Furthermore, the compounds were also tested for antibacterial activity against three Gram-positive (Bacillus subtilis [NCIM 2063], Bacillus cereus [NCIM 2156], Staphylococcus aureus [NCIM 2079]) and two Gram-negative (Escherichia coli [NCIM 2065], Proteus vulgaris [NCIM 2027]) bacteria. The derivatives showed a significant-to-moderate antibacterial activity with noticeable antibiofilm efficacy. Quantitative structure–activity relationship (QSAR), ADME (absorption, distribution, metabolism, elimination) calculation, molecular docking, radial distribution function, and 2D fingerprinting were also performed to elucidate fundamental structural fragments essential for their bioactivity. These studies suggest that the derivatives 10b and 10n have lead antibacterial properties with significant DNA gyrase inhibitory efficacy, and they can serve as a starting scaffold for the further development of new broad-spectrum antibacterial agents.
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies
Alsaif, Nawaf A.,Taghour, Mohammed S.,Alanazi, Mohammed M.,Obaidullah, Ahmad J.,Alanazi, Wael A.,Alasmari, Abdullah,Albassam, Hussam,Dahab, Mohammed A.,Mahdy, Hazem A.
, (2021/09/04)
Tumor angiogenesis is mainly regulated by VEGFR-2. In this study, a new series of [1,2,4]triazolo[4,3-a]quinoxaline based-derivatives has been designed and synthesized to develop new anti-proliferative and anti-VEGFR-2 members. Anti-proliferative activities of the synthesized compounds were tested against MCF-7 and HepG2 cell lines. Compound 19a exhibited the highest activity towards both MCF-7 and HepG2 cell lines (IC50 = 8.2 and 5.4 μM, respectively), compared to sorafenib (IC50 = 3.51 and 2.17 μM, respectively). Additionally, all compounds were screened to evaluate their effect as VEGFR-2 inhibitors. Compound 19a (IC50 = 3.4 nM) exhibited good activity compared to sorafenib (IC50 = 3.12 nM). Furthermore, compound 19a disrupted the HepG2 cell cycle by arresting the G2/M phase. Also, marked increase in the percentage apoptotic cells was achieved by compound 19a. The induced apoptotic effect of compound 19a in HepG2 cells was assured by increased pro‐apoptotic marker (Bax) expression by 2.33-fold and decreased anti‐apoptotic (Bcl‐2) expression by 1.88-fold, resulting in an elevation of the Bax/Bcl-2 ratio in HepG2 cells. Comparing to the control cells, compound 19a induced an increase in expression of cleaved caspase-3 and caspase-9 by 2.44- and 2.69-fold, respectively. Finally, the binding modes of the target derivatives were investigated through docking studies against the proposed molecular target (VEGFR-2, PDB ID: 2OH4).
